AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Kura OncologyBioDelivery Sciences InternationalUrogen PharmaCorbus PharmaceuticalsAnaptysBio
SymbolNASDAQ:KURANASDAQ:BDSINASDAQ:URGNNASDAQ:CRBPNASDAQ:ANAB
Price Information
Current Price$16.72$4.77$24.57$7.05$19.40
52 Week RangeBuyBuyBuyBuyHold
Beat the Market™ Rank
Overall Score1.61.91.62.21.2
Analysis Score4.53.43.33.53.1
Community Score2.63.13.13.02.8
Dividend Score0.00.00.00.00.0
Ownership Score1.01.01.04.00.0
Earnings & Valuation Score0.01.90.60.60.0
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyHold
Consensus Price Target$25.50$8.71$45.20$39.80$48.86
% Upside from Price Target52.51% upside82.56% upside83.96% upside464.54% upside151.84% upside
Trade Information
Market Cap$769.30 million$477.54 million$490.45 million$540.78 million$520.45 million
Beta2.30.771.711.450.92
Average Volume522,7391,073,313229,9341,020,019531,577
Sales & Book Value
Annual RevenueN/A$111.39 million$20,000.00$36.14 million$8 million
Price / SalesN/A4.2825,671.9614.1466.15
CashflowN/A$0.18 per shareN/AN/AN/A
Price / CashN/A25.83N/AN/AN/A
Book Value$4.83 per share$0.78 per share$8.63 per share$0.10 per share$14.93 per share
Price / BookN/A6.122.8570.501.30
Profitability
Net Income$-63,140,000.00$-15,310,000.00$-105,150,000.00$-71,450,000.00$-97,340,000.00
EPS($1.51)$0.10($5.12)($1.12)($3.60)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/A10.84N/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A-5.01%N/A-207.87%N/A
Return on Equity (ROE)-30.33%23.61%-63.41%-282.91%-19.95%
Return on Assets (ROA)-27.68%9.21%-58.23%-112.34%-18.65%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.03%0.77%N/A0.35%N/A
Current Ratio15.19%2.19%8.58%1.58%15.96%
Quick Ratio15.19%1.94%8.58%1.58%15.96%
Ownership Information
Institutional Ownership Percentage87.35%73.64%64.41%48.75%N/A
Insider Ownership Percentage7.20%8.94%12.00%8.20%14.00%
Miscellaneous
Employees431787014178
Shares Outstanding45.44 million99.90 million20.90 million72.49 million27.28 million
Next Earnings Date8/6/2020 (Estimated)8/13/2020 (Estimated)8/14/2020 (Estimated)8/13/2020 (Estimated)8/13/2020 (Estimated)
OptionableOptionableOptionableOptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.